Compounds > 10-hydroxycamptothecin
Page last updated: 2024-08-26

10-hydroxycamptothecin and Cancer of Nasopharynx

10-hydroxycamptothecin has been researched along with Cancer of Nasopharynx in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bu, XZ; Gu, LQ; Shen, YD; Tian, YX1
Chen, SB; Gu, LQ; Huang, SL; Huang, ZH; Huang, ZS; Li, D; Ou, JB; Ou, TM; Shen, LL; Tan, JH; Wu, WB1
Chen, LM; Ding, Y; Fu, LW; Liang, YJ; Pan, QC; Xiong, HY; Yang, XP1

Other Studies

3 other study(ies) available for 10-hydroxycamptothecin and Cancer of Nasopharynx

ArticleYear
Natural tanshinone-like heterocyclic-fused ortho-quinones from regioselective Diels-Alder reaction: synthesis and cytotoxicity evaluation.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:10

    Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Furans; Humans; Lung Neoplasms; Models, Molecular; Molecular Structure; Naphthoquinones; Nasopharyngeal Neoplasms; Stereoisomerism; Structure-Activity Relationship

2009
Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Survival; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Etoposide; Humans; Inhibitory Concentration 50; Lung Neoplasms; Naphthoquinones; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Plasmids; Pyrans; Quinones; Sesquiterpenes; Structure-Activity Relationship; Telomerase; Topoisomerase Inhibitors

2011
[Experimental studies on treatment of nasopharyngeal carcinoma with combination regimen of hydroxycamptothecin and etoposide].
    Ai zheng = Aizheng = Chinese journal of cancer, 2003, Volume: 22, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Etoposide; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2003